Considerations for Potency Assay Development for Gene Editing Products

Time: 2:00 pm
day: Conference Day 2

Details:

  • Overview of matrix approach for potency assay development
  • Review of available regulatory guidance and expectations for a phased-based approach to potency assay development
  • Tools and considerations when measuring biological cascade of RNA & LNP delivery in-vitro 
  • Challenges associated with potency assay development for gene editing products

Speakers: